Menagen en es it fr

Menagen Brand names, Menagen Analogs

Menagen Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Menagen Chemical_Formula


Menagen RX_link

No information avaliable

Menagen fda sheet

Menagen msds (material safety sheet)

Menagen MSDS

Menagen Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Menagen Molecular Weight

270.366 g/mol

Menagen Melting Point

254.5-256 oC

Menagen H2O Solubility

3 g/100mL

Menagen State


Menagen LogP


Menagen Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Menagen Indication

For management of Menopausal and postmenopausal disorders

Menagen Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Menagen Absorption


Menagen side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Menagen Patient Information

Menagen Organisms Affected

Humans and other mammals